CLRB - CIK 0001279704
Cellectar Biosciences, Inc. has filed 1,001 documents with the SEC between 2011 and 2026. The most frequent type is major company event (367 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| S-1/A | - | 2026-05-29 | - |
| IPO registration | S-1 | 2026-05-19 | - |
| PRE 14A | - | 2026-05-18 | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 | 2026-05-17 |
| Major company event | 8-K | 2026-05-14 | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-14 | 2026-03-31 |
| Insider trade | 4 | 2026-05-11 | 2026-05-07 |
| Insider trade | 4 | 2026-05-11 | 2026-05-07 |
| SCHEDULE 13G | - | 2026-05-11 | - |
| Major company event | 8-K | 2026-05-08 | 2026-05-04 |
| Prospectus supplement | 424B5 | 2026-05-06 | - |
| Annual report (amended) | 10-K/A | 2026-04-30 | 2025-12-31 |
| Major company event | 8-K | 2026-03-04 | 2026-03-04 |
| Annual report | 10-K | 2026-03-04 | 2025-12-31 |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| SCHEDULE 13G/A | - | 2026-02-10 | - |
| SCHEDULE 13G/A | - | 2026-02-04 | - |
| Insider trade | 4 | 2025-12-16 | 2025-12-12 |
| 424B3 | - | 2025-11-21 | - |
| SCHEDULE 13G | - | 2025-11-14 | - |
| Major company event | 8-K | 2025-11-13 | 2025-11-13 |
| Quarterly report | 10-Q | 2025-11-13 | 2025-09-30 |
| IPO registration | S-1 | 2025-10-20 | - |
| Major company event | 8-K | 2025-10-10 | 2025-10-07 |
| Major company event | 8-K | 2025-10-06 | 2025-10-06 |
| Quarterly report | 10-Q | 2025-08-14 | 2025-06-30 |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| Major company event | 8-K | 2025-08-14 | 2025-08-14 |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13G | - | 2025-08-08 | - |
| SCHEDULE 13G | - | 2025-07-08 | - |
| Insider trade | 4 | 2025-07-03 | 2025-07-02 |
| Insider trade | 4 | 2025-07-03 | 2025-07-02 |
| Insider trade | 4 | 2025-07-03 | 2025-07-02 |
| 424B4 | - | 2025-07-02 | - |
| EFFECT | - | 2025-07-01 | - |
| Company correspondence | CORRESP | 2025-06-30 | - |
| Company correspondence | CORRESP | 2025-06-30 | - |
| S-1/A | - | 2025-06-30 | - |
| Major company event | 8-K | 2025-06-26 | 2025-06-26 |
| IPO registration | S-1 | 2025-06-26 | - |
| Major company event | 8-K | 2025-06-25 | 2025-06-24 |
| Major company event | 8-K | 2025-06-18 | 2025-06-18 |
| Major company event | 8-K | 2025-06-13 | 2025-06-13 |
| Proxy materials | DEFA14A | 2025-06-11 | - |
| Major company event | 8-K | 2025-06-05 | 2025-06-05 |
| SEC correspondence | UPLOAD | 2025-05-29 | - |
| DRS | - | 2025-05-23 | - |
| Quarterly report | 10-Q | 2025-05-13 | 2025-03-31 |